parkinson's and glutathione Central nervous system uptake of intranasal in disease Glutathione, iron and Parkinson's disease

Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial

Blockade of adenosine A2A receptors prevents interleukin-1-induced exacerbation of neuronal toxicity through a p38 mitogen-activated protein kinase pathway

analyzed the effects of MT on biomass and astaxanthin content in P

Wegovy Pill was also recently approved by the FDA in December 2025

It is interesting to note that despite the postischemic damage or even death of neurons, a large part of the decreased glutamate amount seen after the ischemic event in the brain is replaced in the 72-hour reperfusion period